Skip to content

Assessment of Heart Rate Variability HRV During Descent DE From 2850m to Sea Level and During Re-ascent A From Sea Level to 2850m in Healthy Individuals H

Effect of a One-week Descent From 2850m to Sea Level and Re-ascent in Patients With Pulmonary Arterial Hypertension and Healthy Controls Permanently Living > 2600m on Pulmonary Hemodynamics, Exercise Capacity, Blood Oxygenation, Sleep Disordered Breathing and Further Outcomes

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07801846
Enrollment
14
Registered
2026-09-03
Start date
2026-09-25
Completion date
2026-12-31
Last updated
2026-09-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

ECG Abnormalities, Healthy, Healthy Adult, Heart Rate Variability (HRV), High Altitude, High Altitude Effects

Keywords

Health, High altitude, Heart rate variability, ECG, Arrhythmias, Pulse transit time

Brief summary

To study the effect of relocation from high altitude (Quito Ecuador: 2850m) to sea level and re-ascent from sea level to 2850m on heart rate variability and other hemodynamic parameters in healthy individuals, who live permanently \>2600m.

Detailed description

The aim of this research is to investigate the heart rate variability and other hemodynamic outcomes during the descent from 2850m to sea level and during re-ascent from sea level to 2850m in healthy individuals, who permanently live at high altitude over 2600m

Interventions

Descent from 2850m to sea level (in one day by bus) and re-ascent after 7 days from sea level to 2850m (in one day by bus)

Sponsors

Silvia Ulrich Somaini
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Intervention model description

Healthy participants living permanently \> 2600m around Quito (Ecuador) will be assessed during descent from 2850m to sea level and during re-ascent after one week from sea level to 2850m

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
Yes

Inclusion criteria

* Adults aged 18-80 years and of all genders * Permanent residence \> 2600 m * healthy: no self perceived cardiopulmonary disease limiting daily activities * written informed consent to participate in the study.

Exclusion criteria

* Age \<18 years or \>80 years * Participants who cannot follow the study investigations * Participants permanently living \< 2600m * Participants who traveled and stayed overnight at altitudes \<2000 m in the past 4 weeks. * any self-perceived cardiopulmonary disease limiting daily activities

Design outcomes

Primary

MeasureTime frameDescription
Heart rate variability HRV during descent and re-ascentFrom day of descent (day 1) and day of re-ascent (day 8)Difference/change in heart rate variability at different altitudes during descent (2850m to sea level) and during re-ascent after 7 days (sea level to 2850m) in healthy individuals

Secondary

MeasureTime frameDescription
SpO2 during descent and re-ascentFrom day of descent (day 1) and day of re-ascent (day 8)Difference/change in SpO2 at different altitudes during descent (2850m to sea level) and during re-ascent after 7 days (sea level to 2850m) in healthy individuals
ECG-Repolarization during descent and re-ascentFrom day of descent (day 1) and day of re-ascent (day 8)Occurrence/changes in cardial arrhythmias at different altitudes during descent (2850m to sea level) and during re-ascent after 7 days (sea level to 2850m) in healthy individuals
Cardial arrhythmias during descent and re-ascentFrom day of descent (day 1) and day of re-ascent (day 8)Occurrence/changes in cardial arrhythmias at different altitudes during descent (2850m to sea level) and during re-ascent after 7 days (sea level to 2850m) in healthy individuals
Pulse transit time during descent and re-ascentFrom day of descent (day 1) and day of re-ascent (day 8)Occurrence and difference/change in pulse transit time (drops) at different altitudes during descent (2850m to sea level) and during re-ascent after 7 days (sea level to 2850m) in healthy individuals

Countries

Switzerland

Contacts

CONTACTSilvia Ulrich, Prof. Dr. med.
silvia.ulrich@usz.ch+41442552220
CONTACTMichael Furian, Prof. Dr. sc. ETH
+41442552220
PRINCIPAL_INVESTIGATORSilvia Ulrich

University Hospital Zurich, Departement of Pulmonology

PRINCIPAL_INVESTIGATORRodrigo Hoyos

Hospital Carlos Andrade Marin of Quito, Ecuador

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Sep 4, 2026